Vertex Pharmaceuticals and bluebird bio have entered into an agreement with CMS to participate in a new Medicaid payment model for gene-based sickle cell anemia treatments, the agency announced ...
This whitepaper explores the role of process analytical technology (PAT) in enhancing the efficiency of upstream ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果